Nph Insulin — FDA Animal & Veterinary Adverse Event (ADE) Reports
Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Nph Insulin is a active ingredient.
Total reports
Nph Insulin: 46
Reports by species (top entries)
- Dog 45
- Cat 1
Top reported reactions (VEDDRA terms, top entries)
- Hyperglycaemia 21
- Weight loss 14
- Hyperkalaemia 13
- Hyponatremia 8
- Lethargy (see also Central nervous system depression in 'Neurological') 8
- Other abnormal test result NOS 8
- Vomiting 8
- Elevated alanine aminotransferase (ALT) 7
- Elevated serum alkaline phosphatase (SAP) 7
- Hypoglycaemia 7
Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b24.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).